ESR1 Gene Mutation
Drug | Drug Name | Drug Description |
---|---|---|
DB06374 | Elacestrant | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00675 | Tamoxifen | 0 | Recruiting | 1 |
DB01234 | Dexamethasone | 3 | Not Yet Recruiting | 1 |
DB06374 | Elacestrant | 3 | Not Yet Recruiting | 1 |
DB01175 | Escitalopram | 3 | Not Yet Recruiting | 1 |
DB00783 | Estradiol | 3 | Not Yet Recruiting | 1 |
DB01590 | Everolimus | 3 | Not Yet Recruiting | 1 |
DB14741 | Luteinizing hormone | 3 | Not Yet Recruiting | 1 |